The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Insulin Needle-Free Injection Device Market Research Report 2025
Synopsis
An insulin needleless injection device is a medical device used to administer insulin therapy that allows patients to inject insulin through the surface of the skin without using a traditional injection needle. This device usually uses a special technology, such as a high-pressure gas or high-speed liquid jet, to spray a dose of insulin onto the surface of the skin, where it is then absorbed through the skin into the bloodstream.
The global Insulin Needle-Free Injection Device market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Insulin Needle-Free Injection Device is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Insulin Needle-Free Injection Device is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Insulin Needle-Free Injection Device include 3M, Bioject Medical Technologies, Eternity Healthcare, Crossject, National Medical Products, Valeritas, Neo Laboratories, PharmaJet, Medical International Technology, Bespak, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Insulin Needle-Free Injection Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin Needle-Free Injection Device.
The Insulin Needle-Free Injection Device market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Insulin Needle-Free Injection Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Insulin Needle-Free Injection Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
3M
Bioject Medical Technologies
Eternity Healthcare
Crossject
National Medical Products
Valeritas
Neo Laboratories
PharmaJet
Medical International Technology
Bespak
Zogenix
Advantajet
InsuJet
Antares Pharma
D'Antonio Consultants International
PenJet Corporation
Segment by Type
Compressed
Liquid Jet
Segment by Application
Hospital
Clinic
Rehabilitation Center
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Insulin Needle-Free Injection Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Insulin Needle-Free Injection Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
An insulin needleless injection device is a medical device used to administer insulin therapy that allows patients to inject insulin through the surface of the skin without using a traditional injection needle. This device usually uses a special technology, such as a high-pressure gas or high-speed liquid jet, to spray a dose of insulin onto the surface of the skin, where it is then absorbed through the skin into the bloodstream.
The global Insulin Needle-Free Injection Device market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Insulin Needle-Free Injection Device is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Insulin Needle-Free Injection Device is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Insulin Needle-Free Injection Device include 3M, Bioject Medical Technologies, Eternity Healthcare, Crossject, National Medical Products, Valeritas, Neo Laboratories, PharmaJet, Medical International Technology, Bespak, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Insulin Needle-Free Injection Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin Needle-Free Injection Device.
The Insulin Needle-Free Injection Device market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Insulin Needle-Free Injection Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Insulin Needle-Free Injection Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
3M
Bioject Medical Technologies
Eternity Healthcare
Crossject
National Medical Products
Valeritas
Neo Laboratories
PharmaJet
Medical International Technology
Bespak
Zogenix
Advantajet
InsuJet
Antares Pharma
D'Antonio Consultants International
PenJet Corporation
Segment by Type
Compressed
Liquid Jet
Segment by Application
Hospital
Clinic
Rehabilitation Center
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Insulin Needle-Free Injection Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Insulin Needle-Free Injection Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Insulin Needle-Free Injection Device Market Overview
1.1 Product Definition
1.2 Insulin Needle-Free Injection Device by Type
1.2.1 Global Insulin Needle-Free Injection Device Market Value Comparison by Type (2024-2030)
1.2.2 Compressed
1.2.3 Liquid Jet
1.3 Insulin Needle-Free Injection Device by Application
1.3.1 Global Insulin Needle-Free Injection Device Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Rehabilitation Center
1.3.5 Others
1.4 Global Insulin Needle-Free Injection Device Market Size Estimates and Forecasts
1.4.1 Global Insulin Needle-Free Injection Device Revenue 2019-2030
1.4.2 Global Insulin Needle-Free Injection Device Sales 2019-2030
1.4.3 Global Insulin Needle-Free Injection Device Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Insulin Needle-Free Injection Device Market Competition by Manufacturers
2.1 Global Insulin Needle-Free Injection Device Sales Market Share by Manufacturers (2019-2024)
2.2 Global Insulin Needle-Free Injection Device Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Insulin Needle-Free Injection Device Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Insulin Needle-Free Injection Device, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Insulin Needle-Free Injection Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Insulin Needle-Free Injection Device, Product Type & Application
2.7 Global Key Manufacturers of Insulin Needle-Free Injection Device, Date of Enter into This Industry
2.8 Global Insulin Needle-Free Injection Device Market Competitive Situation and Trends
2.8.1 Global Insulin Needle-Free Injection Device Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Insulin Needle-Free Injection Device Players Market Share by Revenue
2.8.3 Global Insulin Needle-Free Injection Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Insulin Needle-Free Injection Device Market Scenario by Region
3.1 Global Insulin Needle-Free Injection Device Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Insulin Needle-Free Injection Device Sales by Region: 2019-2030
3.2.1 Global Insulin Needle-Free Injection Device Sales by Region: 2019-2024
3.2.2 Global Insulin Needle-Free Injection Device Sales by Region: 2025-2030
3.3 Global Insulin Needle-Free Injection Device Revenue by Region: 2019-2030
3.3.1 Global Insulin Needle-Free Injection Device Revenue by Region: 2019-2024
3.3.2 Global Insulin Needle-Free Injection Device Revenue by Region: 2025-2030
3.4 North America Insulin Needle-Free Injection Device Market Facts & Figures by Country
3.4.1 North America Insulin Needle-Free Injection Device Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Insulin Needle-Free Injection Device Sales by Country (2019-2030)
3.4.3 North America Insulin Needle-Free Injection Device Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Insulin Needle-Free Injection Device Market Facts & Figures by Country
3.5.1 Europe Insulin Needle-Free Injection Device Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Insulin Needle-Free Injection Device Sales by Country (2019-2030)
3.5.3 Europe Insulin Needle-Free Injection Device Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Insulin Needle-Free Injection Device Market Facts & Figures by Region
3.6.1 Asia Pacific Insulin Needle-Free Injection Device Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Insulin Needle-Free Injection Device Sales by Region (2019-2030)
3.6.3 Asia Pacific Insulin Needle-Free Injection Device Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Insulin Needle-Free Injection Device Market Facts & Figures by Country
3.7.1 Latin America Insulin Needle-Free Injection Device Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Insulin Needle-Free Injection Device Sales by Country (2019-2030)
3.7.3 Latin America Insulin Needle-Free Injection Device Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Insulin Needle-Free Injection Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Insulin Needle-Free Injection Device Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Insulin Needle-Free Injection Device Sales by Country (2019-2030)
3.8.3 Middle East and Africa Insulin Needle-Free Injection Device Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Insulin Needle-Free Injection Device Sales by Type (2019-2030)
4.1.1 Global Insulin Needle-Free Injection Device Sales by Type (2019-2024)
4.1.2 Global Insulin Needle-Free Injection Device Sales by Type (2025-2030)
4.1.3 Global Insulin Needle-Free Injection Device Sales Market Share by Type (2019-2030)
4.2 Global Insulin Needle-Free Injection Device Revenue by Type (2019-2030)
4.2.1 Global Insulin Needle-Free Injection Device Revenue by Type (2019-2024)
4.2.2 Global Insulin Needle-Free Injection Device Revenue by Type (2025-2030)
4.2.3 Global Insulin Needle-Free Injection Device Revenue Market Share by Type (2019-2030)
4.3 Global Insulin Needle-Free Injection Device Price by Type (2019-2030)
5 Segment by Application
5.1 Global Insulin Needle-Free Injection Device Sales by Application (2019-2030)
5.1.1 Global Insulin Needle-Free Injection Device Sales by Application (2019-2024)
5.1.2 Global Insulin Needle-Free Injection Device Sales by Application (2025-2030)
5.1.3 Global Insulin Needle-Free Injection Device Sales Market Share by Application (2019-2030)
5.2 Global Insulin Needle-Free Injection Device Revenue by Application (2019-2030)
5.2.1 Global Insulin Needle-Free Injection Device Revenue by Application (2019-2024)
5.2.2 Global Insulin Needle-Free Injection Device Revenue by Application (2025-2030)
5.2.3 Global Insulin Needle-Free Injection Device Revenue Market Share by Application (2019-2030)
5.3 Global Insulin Needle-Free Injection Device Price by Application (2019-2030)
6 Key Companies Profiled
6.1 3M
6.1.1 3M Company Information
6.1.2 3M Description and Business Overview
6.1.3 3M Insulin Needle-Free Injection Device Sales, Revenue and Gross Margin (2019-2024)
6.1.4 3M Insulin Needle-Free Injection Device Product Portfolio
6.1.5 3M Recent Developments/Updates
6.2 Bioject Medical Technologies
6.2.1 Bioject Medical Technologies Company Information
6.2.2 Bioject Medical Technologies Description and Business Overview
6.2.3 Bioject Medical Technologies Insulin Needle-Free Injection Device Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bioject Medical Technologies Insulin Needle-Free Injection Device Product Portfolio
6.2.5 Bioject Medical Technologies Recent Developments/Updates
6.3 Eternity Healthcare
6.3.1 Eternity Healthcare Company Information
6.3.2 Eternity Healthcare Description and Business Overview
6.3.3 Eternity Healthcare Insulin Needle-Free Injection Device Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Eternity Healthcare Insulin Needle-Free Injection Device Product Portfolio
6.3.5 Eternity Healthcare Recent Developments/Updates
6.4 Crossject
6.4.1 Crossject Company Information
6.4.2 Crossject Description and Business Overview
6.4.3 Crossject Insulin Needle-Free Injection Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Crossject Insulin Needle-Free Injection Device Product Portfolio
6.4.5 Crossject Recent Developments/Updates
6.5 National Medical Products
6.5.1 National Medical Products Company Information
6.5.2 National Medical Products Description and Business Overview
6.5.3 National Medical Products Insulin Needle-Free Injection Device Sales, Revenue and Gross Margin (2019-2024)
6.5.4 National Medical Products Insulin Needle-Free Injection Device Product Portfolio
6.5.5 National Medical Products Recent Developments/Updates
6.6 Valeritas
6.6.1 Valeritas Company Information
6.6.2 Valeritas Description and Business Overview
6.6.3 Valeritas Insulin Needle-Free Injection Device Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Valeritas Insulin Needle-Free Injection Device Product Portfolio
6.6.5 Valeritas Recent Developments/Updates
6.7 Neo Laboratories
6.7.1 Neo Laboratories Company Information
6.7.2 Neo Laboratories Description and Business Overview
6.7.3 Neo Laboratories Insulin Needle-Free Injection Device Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Neo Laboratories Insulin Needle-Free Injection Device Product Portfolio
6.7.5 Neo Laboratories Recent Developments/Updates
6.8 PharmaJet
6.8.1 PharmaJet Company Information
6.8.2 PharmaJet Description and Business Overview
6.8.3 PharmaJet Insulin Needle-Free Injection Device Sales, Revenue and Gross Margin (2019-2024)
6.8.4 PharmaJet Insulin Needle-Free Injection Device Product Portfolio
6.8.5 PharmaJet Recent Developments/Updates
6.9 Medical International Technology
6.9.1 Medical International Technology Company Information
6.9.2 Medical International Technology Description and Business Overview
6.9.3 Medical International Technology Insulin Needle-Free Injection Device Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Medical International Technology Insulin Needle-Free Injection Device Product Portfolio
6.9.5 Medical International Technology Recent Developments/Updates
6.10 Bespak
6.10.1 Bespak Company Information
6.10.2 Bespak Description and Business Overview
6.10.3 Bespak Insulin Needle-Free Injection Device Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Bespak Insulin Needle-Free Injection Device Product Portfolio
6.10.5 Bespak Recent Developments/Updates
6.11 Zogenix
6.11.1 Zogenix Company Information
6.11.2 Zogenix Description and Business Overview
6.11.3 Zogenix Insulin Needle-Free Injection Device Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Zogenix Insulin Needle-Free Injection Device Product Portfolio
6.11.5 Zogenix Recent Developments/Updates
6.12 Advantajet
6.12.1 Advantajet Company Information
6.12.2 Advantajet Description and Business Overview
6.12.3 Advantajet Insulin Needle-Free Injection Device Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Advantajet Insulin Needle-Free Injection Device Product Portfolio
6.12.5 Advantajet Recent Developments/Updates
6.13 InsuJet
6.13.1 InsuJet Company Information
6.13.2 InsuJet Description and Business Overview
6.13.3 InsuJet Insulin Needle-Free Injection Device Sales, Revenue and Gross Margin (2019-2024)
6.13.4 InsuJet Insulin Needle-Free Injection Device Product Portfolio
6.13.5 InsuJet Recent Developments/Updates
6.14 Antares Pharma
6.14.1 Antares Pharma Company Information
6.14.2 Antares Pharma Description and Business Overview
6.14.3 Antares Pharma Insulin Needle-Free Injection Device Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Antares Pharma Insulin Needle-Free Injection Device Product Portfolio
6.14.5 Antares Pharma Recent Developments/Updates
6.15 D'Antonio Consultants International
6.15.1 D'Antonio Consultants International Company Information
6.15.2 D'Antonio Consultants International Description and Business Overview
6.15.3 D'Antonio Consultants International Insulin Needle-Free Injection Device Sales, Revenue and Gross Margin (2019-2024)
6.15.4 D'Antonio Consultants International Insulin Needle-Free Injection Device Product Portfolio
6.15.5 D'Antonio Consultants International Recent Developments/Updates
6.16 PenJet Corporation
6.16.1 PenJet Corporation Company Information
6.16.2 PenJet Corporation Description and Business Overview
6.16.3 PenJet Corporation Insulin Needle-Free Injection Device Sales, Revenue and Gross Margin (2019-2024)
6.16.4 PenJet Corporation Insulin Needle-Free Injection Device Product Portfolio
6.16.5 PenJet Corporation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Insulin Needle-Free Injection Device Industry Chain Analysis
7.2 Insulin Needle-Free Injection Device Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Insulin Needle-Free Injection Device Production Mode & Process
7.4 Insulin Needle-Free Injection Device Sales and Marketing
7.4.1 Insulin Needle-Free Injection Device Sales Channels
7.4.2 Insulin Needle-Free Injection Device Distributors
7.5 Insulin Needle-Free Injection Device Customers
8 Insulin Needle-Free Injection Device Market Dynamics
8.1 Insulin Needle-Free Injection Device Industry Trends
8.2 Insulin Needle-Free Injection Device Market Drivers
8.3 Insulin Needle-Free Injection Device Market Challenges
8.4 Insulin Needle-Free Injection Device Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Insulin Needle-Free Injection Device Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Insulin Needle-Free Injection Device Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Insulin Needle-Free Injection Device Market Competitive Situation by Manufacturers in 2023
Table 4. Global Insulin Needle-Free Injection Device Sales (Units) of Key Manufacturers (2019-2024)
Table 5. Global Insulin Needle-Free Injection Device Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Insulin Needle-Free Injection Device Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Insulin Needle-Free Injection Device Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Insulin Needle-Free Injection Device Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Insulin Needle-Free Injection Device, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Insulin Needle-Free Injection Device, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Insulin Needle-Free Injection Device, Product Type & Application
Table 12. Global Key Manufacturers of Insulin Needle-Free Injection Device, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Insulin Needle-Free Injection Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Needle-Free Injection Device as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Insulin Needle-Free Injection Device Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Insulin Needle-Free Injection Device Sales by Region (2019-2024) & (Units)
Table 18. Global Insulin Needle-Free Injection Device Sales Market Share by Region (2019-2024)
Table 19. Global Insulin Needle-Free Injection Device Sales by Region (2025-2030) & (Units)
Table 20. Global Insulin Needle-Free Injection Device Sales Market Share by Region (2025-2030)
Table 21. Global Insulin Needle-Free Injection Device Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Insulin Needle-Free Injection Device Revenue Market Share by Region (2019-2024)
Table 23. Global Insulin Needle-Free Injection Device Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Insulin Needle-Free Injection Device Revenue Market Share by Region (2025-2030)
Table 25. North America Insulin Needle-Free Injection Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Insulin Needle-Free Injection Device Sales by Country (2019-2024) & (Units)
Table 27. North America Insulin Needle-Free Injection Device Sales by Country (2025-2030) & (Units)
Table 28. North America Insulin Needle-Free Injection Device Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Insulin Needle-Free Injection Device Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Insulin Needle-Free Injection Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Insulin Needle-Free Injection Device Sales by Country (2019-2024) & (Units)
Table 32. Europe Insulin Needle-Free Injection Device Sales by Country (2025-2030) & (Units)
Table 33. Europe Insulin Needle-Free Injection Device Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Insulin Needle-Free Injection Device Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Insulin Needle-Free Injection Device Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Insulin Needle-Free Injection Device Sales by Region (2019-2024) & (Units)
Table 37. Asia Pacific Insulin Needle-Free Injection Device Sales by Region (2025-2030) & (Units)
Table 38. Asia Pacific Insulin Needle-Free Injection Device Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Insulin Needle-Free Injection Device Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Insulin Needle-Free Injection Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Insulin Needle-Free Injection Device Sales by Country (2019-2024) & (Units)
Table 42. Latin America Insulin Needle-Free Injection Device Sales by Country (2025-2030) & (Units)
Table 43. Latin America Insulin Needle-Free Injection Device Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Insulin Needle-Free Injection Device Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Insulin Needle-Free Injection Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Insulin Needle-Free Injection Device Sales by Country (2019-2024) & (Units)
Table 47. Middle East and Africa Insulin Needle-Free Injection Device Sales by Country (2025-2030) & (Units)
Table 48. Middle East and Africa Insulin Needle-Free Injection Device Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Insulin Needle-Free Injection Device Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Insulin Needle-Free Injection Device Sales (Units) by Type (2019-2024)
Table 51. Global Insulin Needle-Free Injection Device Sales (Units) by Type (2025-2030)
Table 52. Global Insulin Needle-Free Injection Device Sales Market Share by Type (2019-2024)
Table 53. Global Insulin Needle-Free Injection Device Sales Market Share by Type (2025-2030)
Table 54. Global Insulin Needle-Free Injection Device Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Insulin Needle-Free Injection Device Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Insulin Needle-Free Injection Device Revenue Market Share by Type (2019-2024)
Table 57. Global Insulin Needle-Free Injection Device Revenue Market Share by Type (2025-2030)
Table 58. Global Insulin Needle-Free Injection Device Price (US$/Unit) by Type (2019-2024)
Table 59. Global Insulin Needle-Free Injection Device Price (US$/Unit) by Type (2025-2030)
Table 60. Global Insulin Needle-Free Injection Device Sales (Units) by Application (2019-2024)
Table 61. Global Insulin Needle-Free Injection Device Sales (Units) by Application (2025-2030)
Table 62. Global Insulin Needle-Free Injection Device Sales Market Share by Application (2019-2024)
Table 63. Global Insulin Needle-Free Injection Device Sales Market Share by Application (2025-2030)
Table 64. Global Insulin Needle-Free Injection Device Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Insulin Needle-Free Injection Device Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Insulin Needle-Free Injection Device Revenue Market Share by Application (2019-2024)
Table 67. Global Insulin Needle-Free Injection Device Revenue Market Share by Application (2025-2030)
Table 68. Global Insulin Needle-Free Injection Device Price (US$/Unit) by Application (2019-2024)
Table 69. Global Insulin Needle-Free Injection Device Price (US$/Unit) by Application (2025-2030)
Table 70. 3M Company Information
Table 71. 3M Description and Business Overview
Table 72. 3M Insulin Needle-Free Injection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. 3M Insulin Needle-Free Injection Device Product
Table 74. 3M Recent Developments/Updates
Table 75. Bioject Medical Technologies Company Information
Table 76. Bioject Medical Technologies Description and Business Overview
Table 77. Bioject Medical Technologies Insulin Needle-Free Injection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Bioject Medical Technologies Insulin Needle-Free Injection Device Product
Table 79. Bioject Medical Technologies Recent Developments/Updates
Table 80. Eternity Healthcare Company Information
Table 81. Eternity Healthcare Description and Business Overview
Table 82. Eternity Healthcare Insulin Needle-Free Injection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Eternity Healthcare Insulin Needle-Free Injection Device Product
Table 84. Eternity Healthcare Recent Developments/Updates
Table 85. Crossject Company Information
Table 86. Crossject Description and Business Overview
Table 87. Crossject Insulin Needle-Free Injection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Crossject Insulin Needle-Free Injection Device Product
Table 89. Crossject Recent Developments/Updates
Table 90. National Medical Products Company Information
Table 91. National Medical Products Description and Business Overview
Table 92. National Medical Products Insulin Needle-Free Injection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. National Medical Products Insulin Needle-Free Injection Device Product
Table 94. National Medical Products Recent Developments/Updates
Table 95. Valeritas Company Information
Table 96. Valeritas Description and Business Overview
Table 97. Valeritas Insulin Needle-Free Injection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Valeritas Insulin Needle-Free Injection Device Product
Table 99. Valeritas Recent Developments/Updates
Table 100. Neo Laboratories Company Information
Table 101. Neo Laboratories Description and Business Overview
Table 102. Neo Laboratories Insulin Needle-Free Injection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Neo Laboratories Insulin Needle-Free Injection Device Product
Table 104. Neo Laboratories Recent Developments/Updates
Table 105. PharmaJet Company Information
Table 106. PharmaJet Description and Business Overview
Table 107. PharmaJet Insulin Needle-Free Injection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. PharmaJet Insulin Needle-Free Injection Device Product
Table 109. PharmaJet Recent Developments/Updates
Table 110. Medical International Technology Company Information
Table 111. Medical International Technology Description and Business Overview
Table 112. Medical International Technology Insulin Needle-Free Injection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Medical International Technology Insulin Needle-Free Injection Device Product
Table 114. Medical International Technology Recent Developments/Updates
Table 115. Bespak Company Information
Table 116. Bespak Description and Business Overview
Table 117. Bespak Insulin Needle-Free Injection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Bespak Insulin Needle-Free Injection Device Product
Table 119. Bespak Recent Developments/Updates
Table 120. Zogenix Company Information
Table 121. Zogenix Description and Business Overview
Table 122. Zogenix Insulin Needle-Free Injection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Zogenix Insulin Needle-Free Injection Device Product
Table 124. Zogenix Recent Developments/Updates
Table 125. Advantajet Company Information
Table 126. Advantajet Description and Business Overview
Table 127. Advantajet Insulin Needle-Free Injection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Advantajet Insulin Needle-Free Injection Device Product
Table 129. Advantajet Recent Developments/Updates
Table 130. InsuJet Company Information
Table 131. InsuJet Description and Business Overview
Table 132. InsuJet Insulin Needle-Free Injection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. InsuJet Insulin Needle-Free Injection Device Product
Table 134. InsuJet Recent Developments/Updates
Table 135. Antares Pharma Company Information
Table 136. Antares Pharma Description and Business Overview
Table 137. Antares Pharma Insulin Needle-Free Injection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Antares Pharma Insulin Needle-Free Injection Device Product
Table 139. Antares Pharma Recent Developments/Updates
Table 140. D'Antonio Consultants International Company Information
Table 141. D'Antonio Consultants International Description and Business Overview
Table 142. D'Antonio Consultants International Insulin Needle-Free Injection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. D'Antonio Consultants International Insulin Needle-Free Injection Device Product
Table 144. D'Antonio Consultants International Recent Developments/Updates
Table 145. PenJet Corporation Company Information
Table 146. PenJet Corporation Description and Business Overview
Table 147. PenJet Corporation Insulin Needle-Free Injection Device Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. PenJet Corporation Insulin Needle-Free Injection Device Product
Table 149. PenJet Corporation Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Insulin Needle-Free Injection Device Distributors List
Table 153. Insulin Needle-Free Injection Device Customers List
Table 154. Insulin Needle-Free Injection Device Market Trends
Table 155. Insulin Needle-Free Injection Device Market Drivers
Table 156. Insulin Needle-Free Injection Device Market Challenges
Table 157. Insulin Needle-Free Injection Device Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Product Picture of Insulin Needle-Free Injection Device
Figure 2. Global Insulin Needle-Free Injection Device Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Insulin Needle-Free Injection Device Market Share by Type: 2023 & 2030
Figure 4. Compressed Product Picture
Figure 5. Liquid Jet Product Picture
Figure 6. Global Insulin Needle-Free Injection Device Market Value by Application (2024-2030) & (US$ Million)
Figure 7. Global Insulin Needle-Free Injection Device Market Share by Application: 2023 & 2030
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Rehabilitation Center
Figure 11. Others
Figure 12. Global Insulin Needle-Free Injection Device Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Insulin Needle-Free Injection Device Market Size (2019-2030) & (US$ Million)
Figure 14. Global Insulin Needle-Free Injection Device Sales (2019-2030) & (Units)
Figure 15. Global Insulin Needle-Free Injection Device Average Price (US$/Unit) & (2019-2030)
Figure 16. Insulin Needle-Free Injection Device Report Years Considered
Figure 17. Insulin Needle-Free Injection Device Sales Share by Manufacturers in 2023
Figure 18. Global Insulin Needle-Free Injection Device Revenue Share by Manufacturers in 2023
Figure 19. Global 5 and 10 Largest Insulin Needle-Free Injection Device Players: Market Share by Revenue in Insulin Needle-Free Injection Device in 2023
Figure 20. Insulin Needle-Free Injection Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 21. Global Insulin Needle-Free Injection Device Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Insulin Needle-Free Injection Device Sales Market Share by Country (2019-2030)
Figure 23. North America Insulin Needle-Free Injection Device Revenue Market Share by Country (2019-2030)
Figure 24. United States Insulin Needle-Free Injection Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Insulin Needle-Free Injection Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Insulin Needle-Free Injection Device Sales Market Share by Country (2019-2030)
Figure 27. Europe Insulin Needle-Free Injection Device Revenue Market Share by Country (2019-2030)
Figure 28. Germany Insulin Needle-Free Injection Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Insulin Needle-Free Injection Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Insulin Needle-Free Injection Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Insulin Needle-Free Injection Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Insulin Needle-Free Injection Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Insulin Needle-Free Injection Device Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Insulin Needle-Free Injection Device Revenue Market Share by Region (2019-2030)
Figure 35. China Insulin Needle-Free Injection Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Insulin Needle-Free Injection Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Insulin Needle-Free Injection Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Insulin Needle-Free Injection Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Insulin Needle-Free Injection Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Insulin Needle-Free Injection Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Southeast Asia Insulin Needle-Free Injection Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Insulin Needle-Free Injection Device Sales Market Share by Country (2019-2030)
Figure 43. Mexico Insulin Needle-Free Injection Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Brazil Insulin Needle-Free Injection Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Argentina Insulin Needle-Free Injection Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Colombia Insulin Needle-Free Injection Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East and Africa Insulin Needle-Free Injection Device Sales Market Share by Country (2019-2030)
Figure 48. Middle East and Africa Insulin Needle-Free Injection Device Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Insulin Needle-Free Injection Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Insulin Needle-Free Injection Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Insulin Needle-Free Injection Device Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Insulin Needle-Free Injection Device by Type (2019-2030)
Figure 53. Global Revenue Market Share of Insulin Needle-Free Injection Device by Type (2019-2030)
Figure 54. Global Insulin Needle-Free Injection Device Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of Insulin Needle-Free Injection Device by Application (2019-2030)
Figure 56. Global Revenue Market Share of Insulin Needle-Free Injection Device by Application (2019-2030)
Figure 57. Global Insulin Needle-Free Injection Device Price (US$/Unit) by Application (2019-2030)
Figure 58. Insulin Needle-Free Injection Device Value Chain
Figure 59. Insulin Needle-Free Injection Device Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
